These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Validation of a single-stage submaximal treadmill walking test.
    Author: Waddoups L, Wagner D, Fallon J, Heath E.
    Journal: J Sports Sci; 2008 Mar; 26(5):491-7. PubMed ID: 18274946.
    Abstract:
    The single-stage treadmill walking test of Ebbeling et al. is commonly used to predict maximal oxygen consumption (.VO(2max)) from a submaximal effort between 50% and 70% of the participant's age-predicted maximum heart rate. The purpose of this study was to determine if this submaximal test correctly predicts .VO(2max) at the low (50% of maximum heart rate) and high (70% of maximum heart rate) ends of the specified heart rate range for males and females aged 18 - 55 years. Each of the 34 participants completed one low-intensity and one high-intensity trial. The two trials resulted in significantly different estimates of .VO(2max) (low-intensity trial: mean 40.5 ml . kg(-1) . min(-1), s = 9.3; high-intensity trial: 47.5 ml . kg(-1) . min(-1), s = 8.8; P < 0.01). A subset of 22 participants concluded their second trial with a .VO(2max) test (mean 47.9 ml . kg(-1) . min(-1), s = 8.9). The low-intensity trial underestimated (mean difference = -3.5 ml . kg(-1) . min(-1); 95% CI = -6.4 to -0.6 ml . kg(-1) . min(-1); P = 0.02) and the high-intensity trial overestimated (mean difference = 3.5 ml . kg(-1) . min(-1); 95% CI = 1.1 to 6.0 ml . kg(-1) . min(-1); P = 0.01) the measured .VO(2max). The predictive validity of Ebbeling and colleagues' single-stage submaximal treadmill walking test is diminished when performed at the extremes of the specified heart rate range.
    [Abstract] [Full Text] [Related] [New Search]